GlassScriptPhysician profile
Polina Zykova
NPI 1174054761
$6,613.10
in general payments reported to CMS, 2019-2025
34 companies · $2,038 in 2025
The $2,038 reported for 2025 was more than what 77% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $72.36 · 2023: $2,090 · 2024: $2,413 · 2025: $2,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,483 · Education: $57.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,483.29 |
| Education | $57.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $892.91 | 2023-2025 | Korlym |
| Amgen INC. | $745.75 | 2023-2025 | Evenity, Prolia, Tepezza |
| Xeris Pharmaceuticals, INC. | $698.17 | 2023-2025 | Recorlev |
| Medtronic, INC. | $372.85 | 2023-2025 | Minimed 780g, Simplera Sensor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $298.42 | 2023-2025 | Jardiance |
| Novo Nordisk INC | $283.79 | 2023-2025 | Sogroya, Rybelsus, Ozempic |
| Lilly USA, LLC | $269.54 | 2023-2024 | Jardiance, Zepbound, Mounjaro |
| Sanofi-Aventis U.S. LLC | $254.92 | 2023-2025 | |
| Beta Bionics, INC. | $241.62 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Mannkind Corporation | $235.70 | 2023-2025 | Afrezza |
| Insulet Corporation | $221.21 | 2025 | Omnipod |
| Recordati_rare_diseases_inc. | $207.09 | 2024-2025 | Isturisa, Signifor Lar |
| Chiesi USA, INC. | $166.40 | 2024 | Myalept, Mycapssa |
| Abbott Laboratories | $150.35 | 2023-2025 | Freestyle Libre 3 |
| Ascendis Pharma Endocrinology INC | $148.36 | 2025 | Yorvipath |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Soleno Therapeutics, INC. | $141.21 | 2025 | Vykat Xr |
| Tandem Diabetes Care, INC. | $137.83 | 2023-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Neurocrine Biosciences, INC. | $132.53 | 2025 | |
| Dexcom, INC. | $120.09 | 2024-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $108.93 | 2023-2024 | |
| Alexion Pharmaceuticals, INC. | $106.39 | 2023-2024 | Strensiq |
| Abbvie INC. | $85.93 | 2023-2024 | Synthroid |
| Almatica Pharma LLC | $84.62 | 2024 | Teriparatide |
| Intercept Pharmaceuticals, INC. | $72.36 | 2020 | |
| Radius Health, INC. | $72.34 | 2023-2024 | Tymlos |
| Pfizer INC. | $65.69 | 2024-2025 | |
| Antares Pharma, INC. | $60.02 | 2024-2025 | Xyosted |
| Horizon Therapeutics Plc | $57.28 | 2023 | Tepezza |
| Madrigal Pharmaceuticals | $48.02 | 2025 | Rezdiffra |
| Kyowa Kirin, INC. | $46.26 | 2023-2024 | Crysvita |
| Rhythm Pharmaceuticals, INC. | $26.27 | 2025 | Imcivree |
| Rgh Enterprises LLC | $23.14 | 2023 | |
| Sequel Med Tech, LLC | $22.34 | 2025 | Twiist |
| Ascensia Diabetes Care US INC. | $14.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Polina Zykova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.